-
Understanding Racial Differences in Emergency Room Visits for Patients with Lupus
Mar 10, 2025, 14:00 PM -
Outcomes Measured in Multiple Myeloma Trials in the Past 10 Years: Focus on Minimal Residual Disease and Therapy Response
Mar 10, 2025, 14:00 PM -
Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil
Mar 10, 2025, 14:00 PM -
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Importance of Virtual Access for Mental Health Services: Evidence from ESI Population
Mar 10, 2025, 14:00 PM -
Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico
Mar 10, 2025, 14:00 PM -
Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges
Mar 10, 2025, 14:00 PM -
A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization of Tafamidis Patients in the United States
Mar 10, 2025, 14:00 PM -
Economic Impact of Trastuzumab and Its Biosimilars for the Treatment of HER2-Positive Breast Cancer Patients: A Real-World Study in the US
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States
Mar 10, 2025, 14:00 PM -
Indirect Costs Associated With Neovascular Age-Related Macular Degeneration (nAMD) in Colombia
Mar 10, 2025, 14:00 PM -
Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey
Mar 10, 2025, 14:00 PM -
Conceptual Framework for a De Novo Cost-effectiveness Model in Glycogen Storage Disease Type Ia (GSDIa)
Mar 10, 2025, 14:00 PM -
Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC
Mar 10, 2025, 14:00 PM -
Cost-Utility analysis of Dinutuximab Beta in Treating High-Risk Neuroblastoma: A Partitioned Survival Model Using R programming Language
Mar 10, 2025, 14:00 PM
